Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genentech’s Phase III lung cancer trial meets endpoint
The Phase III Atlas study was stopped early on the recommendation of an independent data safety monitoring board after a pre-planned interim analysis showed that combining Tarceva and
The Phase III Atlas study was stopped early on the recommendation of an independent data safety monitoring board after a pre-planned interim analysis showed that combining Tarceva and
Net loss was $5.9 million, or $(0.10) per share, which against revenue of $40.4 million and a net loss of $5.3 million, or $(0.10) per share, in the
MEDI-546 will be studied in patients with scleroderma, a chronic autoimmune disease characterized by hardening and thickening of the skin and other organs. MedImmune has previously entered into
In the company’s ongoing Phase I/II clinical trial, a one-time administration of Epodure, producing and delivering the low dose of 18-25IU/kg/day of the protein erythropoietin (EPO), was sufficient
‘ON’ time represents periods when Parkinson’s patients experience their best level of motor functioning. According to the company, the two safinamide treatment groups of the study (receiving either
In India the company plans to begin marketing the oral herpes device pursuant to the exclusive worldwide distribution rights it acquired from NeuroMed, as previously announced. The company
Under the agreement, eResearchTechnology (ERT) and Integrium will deliver a combined solution to meet the increased demand for centralized cardiac safety and ambulatory blood pressure monitoring (ABPM) services
Jetstream is a peripheral atherectomy catheter designed to remove all kinds of artery-clogging plaque in the lower limbs of patients. According to Pathway, Jetstream G2 is capable of
The CAP trial was a prospective, randomized, double-blind, 26-week study designed to examine the effects of low-dose versus high-dose Lipitor on hsCRP levels in men and women under
The merger creates a late-stage, publicly traded specialty pharmaceutical company engaged in the development and commercialization of proprietary products that address important therapeutic needs in the fields of